Acro Biomedical (ACBM) Total Current Liabilities (2015 - 2026)
Acro Biomedical (ACBM) posted Total Current Liabilities of $448437.0 for Q2 2026, up 11.81% on a QoQ basis from $401062.0 in Q4 2025, and up 20.94% year-over-year from $370797.0 in Q2 2025.
Powered by 
Analysis
Acro Biomedical (ACBM) Total Current Liabilities (2015 - 2026) Analysis & Trends
Acro Biomedical has reported Total Current Liabilities for 12 years, with the latest figure at $448437.0 in Q2 2026.
- On a quarterly basis, Total Current Liabilities rose 20.94% year-over-year to $448437.0 in Q2 2026; TTM through Jun 2026 was $448437.0, a 20.94% increase from a year earlier, with the FY2025 full-year figure at $401062.0, up 22.67% from the prior year.
- Total Current Liabilities was $448437.0 for Q2 2026 at Acro Biomedical, up from $401062.0 in the prior quarter.
- The five-year high for Total Current Liabilities was $448437.0 in Q2 2026, with the low at $65990.0 in Q1 2022.
- Average Total Current Liabilities over 5 years is $277802.4, with a median of $297780.0 recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Total Current Liabilities sank 78.71% in 2022, then surged 272.83% in 2023.
- Over 5 years, Total Current Liabilities stood at $201116.0 in 2022, then soared by 43.49% to $288575.0 in 2023, then rose by 13.3% to $326946.0 in 2024, then grew by 22.67% to $401062.0 in 2025, then rose by 11.81% to $448437.0 in 2026.
- The last three Total Current Liabilities figures came in at $448437.0 (Q2 2026), $401062.0 (Q4 2025), and $436942.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 6.15 Bn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 5.87 Bn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 6.99 Bn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 1.71 Bn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | 120.92 Mn |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 1.05 Bn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 973.50 Mn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 603.60 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | 5.19 Mn |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | 448,437.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 448,437.00 |
| Dec 31, 2025 | 401,062.00 |
| Sep 30, 2025 | 436,942.00 |
| Jun 30, 2025 | 370,797.00 |
| Mar 31, 2025 | 329,081.00 |
| Dec 31, 2024 | 326,946.00 |
| Sep 30, 2024 | 317,304.00 |
| Jun 30, 2024 | 308,029.00 |
| Mar 31, 2024 | 297,780.00 |
| Dec 31, 2023 | 288,575.00 |
| Sep 30, 2023 | 258,640.00 |
| Jun 30, 2023 | 199,494.00 |
| Mar 31, 2023 | 246,033.00 |
| Dec 31, 2022 | 201,116.00 |
| Sep 30, 2022 | 144,958.00 |
| Jun 30, 2022 | 81,456.00 |
| Mar 31, 2022 | 65,990.00 |
| Dec 31, 2021 | 91,651.00 |
| Sep 30, 2021 | 61,610.00 |
| Jun 30, 2021 | 60,158.00 |